Descarga: Factor VIII inhibitors in hemophilia A: rationale and latest evidence Archivo: covidhemo/FVIII inhibitors in Hem A rationale and evidence by GY.pdf Abstract: Factor VIII (FVIII) replacement therapy is the foundation of treatment in hemophilia A and is effective unless a patient develops an alloantibody (inhibitor) against exogenous FVIII. Inhibitor development is currently the most…

Descarga: Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics Archivo: covid-19/The Lancet Respirattory-Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics.pdf In December, 2019, numerous unexplained pneumonia cases occurred in Wuhan, China. This outbreak was confirmed to be caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2),…

Descarga: Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics Archivo: covid-19/Drug Dev Res- Angiotensinreceptorblockersastentative SARS-CoV-2therapeutics.pdf AbstractAt the time of writing this commentary (February 2020), the coronavirus COVID-19 epidemic has already resulted in more fatalities compared with the SARS and MERS coronavirus epidemics combined. Therapeutics that may assist to contain its rapid spread and reduce its high mortality rates are…

Descarga: Angiotensin‑converting enzyme 2 (ACE2) as a SARS‑CoV‑2 receptor: molecular mechanisms and potential therapeutic target Archivo: covid-19/Intensive Care Med Angiotensin converting enzyme 2 ACE2 asa SARS CoV 2 receptor molecular mechanisms andpotential therapeutic target.pdf A novel infectious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected in Wuhan, China, in December 2019. The…

Descarga: Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID‑19) Archivo: covid-19/Intensive Care Med ICU Surviving Sepsis Campaign guidelines onthe management ofcritically ill adults withCoronavirus Disease 2019.pdf Abstract Background: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, Coronavirus Disease…

Descargar PDF — Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 To rapidly communicate information on the global clinical effort against Covid-19, the Journal has initiated a series of case reports that offer important teaching points or novel findings. The case reports should be viewed as observations rather than as recommendations for evaluation or treatment….

Descarga: COVID-19: combining antiviral and anti-inflammatory treatments Archivo: covid-19/COVID19 combining antiviral and anti inflammatory.pdf Both coronavirus disease 2019 (COVID-19) and severe acute respiratory syndrome (SARS) are characterised by an overexuberant inflammatory response and, for SARS, viral load is not correlated with the worsening of symptoms.1,2 In our previous Correspondence to The Lancet,3 we described how BenevolentAI’s proprietary artificial intelligence (AI)-derived knowledge  graph,4…

Descargar PDF — Immune Thrombocytopenic Purpura in a Patient with Covid-19 To rapidly communicate information on the global clinical effort against Covid-19, the Journal has initiated a series of case reports that offer important teaching points or novel findings. The case reports should be viewed as observations rather than as recommendations for evaluation or treatment….